Breaking Down Two Broken Down Biotechs
Kir Kahlon of Scorpion Capital revisits two of his most recent targets, Berkeley Lights ($BLI) and Ginkgo Bioworks Holdings ($DNA).
Kir Kahlon of Scorpion Capital revisits two of his most recent targets, Berkeley Lights ($BLI) and Ginkgo Bioworks Holdings ($DNA).
In this new format where we look to re-examine short theses after the market and company management have had time to process and respond, Carson Block of Muddy Waters Capital does just that for his two most recent targets, Danimer Scientific ($DNMR) and Ke Holdings ($BEKE)